Delisting risk
Shuttle Pharmaceuticals (SHPH)
Pharmaceutical AI software platform with a planned Dogecoin–Litecoin mining operation.
$3.40
Pre-market−0.25 (−6.85%)
At close$3.65(+1.11%)
In millions of USD, except per-share figures
| In millions | Q2 FY23Jun 2023 | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 |
| 1 | 2 | 1 | 1 | 1 | 3 | 2 | 3 | 4 | 2 | 2 | 2 | |
| Research & development | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 |
| 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 2 | 1 | |
| General & administrative | 1 | 1 | 0 | 1 | 1 | 2 | 0 | 1 | 3 | 1 | 2 | 1 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | −1 | −2 | −1 | −1 | −1 | −3 | −2 | −3 | −4 | −2 | −3 | −2 |
| −1 | 0 | 0 | 0 | −1 | −1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −2 | −2 | −2 | −2 | −2 | −4 | −2 | −3 | −4 | −2 | −3 | −2 |
| Net income from continuing operations | −2 | −2 | −2 | −2 | −2 | −4 | −2 | −3 | −4 | −2 | −3 | −2 |
| Net income | −2 | −2 | −2 | −2 | −2 | −4 | −2 | −3 | −4 | −2 | −3 | −2 |
| EPS, basic | −$0.15 | −$0.11 | −$1.00 | −$1.00 | −$2.00 | −$3.70 | −$5.40 | −$7.50 | −$32.90 | −$10.50 | −$12.90 | −$4.30 |
| EPS, diluted | −$0.15 | −$0.11 | −$1.00 | −$1.00 | −$2.00 | −$3.70 | −$5.50 | −$7.50 | −$32.90 | −$10.50 | −$12.90 | −$4.30 |
| Weighted average shares, basic | 14 | 16 | 2 | — | — | — | — | — | — | 0 | — | 1 |
| Weighted average shares, diluted | 14 | 16 | 2 | — | — | — | — | — | — | 0 | — | 1 |
| EBITDA | −1 | −1 | −1 | −1 | −2 | −4 | −1 | −3 | −4 | −2 | −2 | −2 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| EBIT | −1 | −1 | −1 | −1 | −2 | −4 | −1 | −3 | −4 | −2 | −3 | −2 |
